Neurodegenerative Disease

NEW YORK — September 11, 2026 Quantum BioPharma Ltd. announced that the U.S. Food and Drug Administration has cleared...

Hong Kong, September 1, 2026 Insilico Medicine, a clinical-stage biotechnology company powered by generative artificial intelligence (AI), has announced...

PALO ALTO, Calif., September 2, 2026 BridgeBio Pharma, Inc. announced plans to present new clinical data on the impact...

LEXINGTON, Mass. and AMSTERDAM, September 2, 2026 uniQure N.V. announced the submission of a Biologics License Application (BLA) to...

TEL AVIV, Israel, Aug. 31, 2026 NeuroSense Therapeutics Ltd. announced an accelerated and capital-efficient development strategy for PrimeC, its...

Milan, Italy – August 28, 2026 Zambon announced that the European Commission has granted marketing authorization for Hopledo® (modified-release...

Seongnam, South Korea, August 14, 2026 SK bioscience has submitted a Clinical Trial Application (CTA) to the South African...

Basel, Switzerland, August 13, 2026 Genedata, a Danaher company providing enterprise software for biopharmaceutical research and development, has launched...

NEW YORK, August 12, 2026 Definium Therapeutics, Inc. announced positive topline results from the Phase 3 Voyage study evaluating...

MELBOURNE, Australia and SAN FRANCISCO, USA, August 12, 2026 Alterity Therapeutics Limited announced that the U.S. Patent and Trademark...